ArticleGlycoconjugate journal2026
Integrating plasma protein-centric multi-omics to evaluate the causal effect of glycosylation on the risk of cancer.
Article in Glycoconjugate journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Glycosylation is a crucial post-translational modification, and numerous studies have reported its significant role in cancer progression. Nevertheless, no study has comprehensively analyzed the causal effect of glycosylation on the risk of cancer till now. Herein, we identified 32 SNPs of glycosylation-related genes (GRGs) that correlated with the risk of 8 kinds of cancer by summary-statistics-based mendelian randomization (SMR) analysis for genome-wide association study (GWAS) data. Next, the heterogeneity in dependent instrument (HEIDI) test and colocalisation analysis were utilized to verify the heterogeneity and consistency of SMR results. Further fine-mapping of causal gene set (FOCUS) analysis based on transcriptome-wide association study (TWAS) data showed that rs9810189 of ST6GAL1 and rs223489 of MANBA were negatively correlated with the risk of breast cancer and squamous cell carcinoma, respectively. Moreover, the MANBA protein in blood plasma also exhibited a probably negative causal effect on squamous cell carcinoma according to two-sample MR analyses for protein quantitative trait locus (pQTLs). In addition, single-cell RNA sequencing analysis and Kaplan-Meier plot analysis were performed to evaluate the potential role of GRGs in corresponding cancer prioritized by the above MR analysis. Finally, we attempted to illustrate the function of glycosyltransferases and investigate the druggable status of GRGs. Together, our study comprehensively analyzed the causal effect of glycosylation on cancer risk and identified potential strategies for cancer treatment.
Indexed as
Identifiers
41493646What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.